Locoregional Therapy Plus Systemic Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma

JOURNAL ARTICLE published 1 June 2020 in JAMA Oncology

Authors: Xu Yang | Jie Pan | Haitao Zhao

When Somatic Mutations Are Associated With a Higher Aggressive Behavior—A Story of Announced Evidence

JOURNAL ARTICLE published 1 October 2017 in JAMA Oncology

Authors: Esther Diana Rossi | Maurizio Martini | Luigi Maria Larocca

Design of Noninferiority Trials for Hypofractionated vs Conventional Radiotherapy Among Patients With Cancer

JOURNAL ARTICLE published 1 October 2019 in JAMA Oncology

Authors: Guosheng Yin | Zachary R. McCaw

Deferring a Change in the Standard of Care for Small Cell Lung Cancer Brain Metastases—Reply

JOURNAL ARTICLE published 1 January 2021 in JAMA Oncology

Authors: Chad G. Rusthoven | Paul D. Brown | Tyler P. Robin

Moving Beyond Limited and Extensive Staging of Small Cell Lung Cancer

JOURNAL ARTICLE published 14 March 2019 in JAMA Oncology

Authors: Howard (Jack) West

Questionable Survival Benefit of Aspirin Use in Patients With Biliary Tract Cancer

JOURNAL ARTICLE published 1 May 2020 in JAMA Oncology

Authors: John R. Bergquist | Omair A. Shariq | Brendan C. Visser

Hypofractionated Radiotherapy for Locally Advanced Non–Small Cell Lung Cancer—Does Size Matter?—Reply

JOURNAL ARTICLE published 1 March 2022 in JAMA Oncology

Authors: Elizabeth Zhang-Velten | Puneeth Iyengar | Robert D. Timmerman

Incorrect Author Affiliation

JOURNAL ARTICLE published 1 May 2019 in JAMA Oncology

Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients With Advanced Gastric Cancer

JOURNAL ARTICLE published 1 April 2021 in JAMA Oncology

Authors: Zachary R. McCaw | Ethan B. Ludmir | Lee-Jen Wei

Error in Figure

JOURNAL ARTICLE published 1 January 2020 in JAMA Oncology

Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin—In Reply

JOURNAL ARTICLE published 1 June 2019 in JAMA Oncology

Authors: Tracey G. Simon | Andrew T. Chan

Posterior Subglottic Mass in a Patient With a History of Rectal Adenocarcinoma and Lung Metastases

JOURNAL ARTICLE published 1 December 2020 in JAMA Oncology

Authors: Forrest Craig | Geraldine O’Sullivan Coyne | Clint T. Allen

Stereotactic Ablative Body Radiotherapy for Metastases Needs Better Evidence

JOURNAL ARTICLE published 1 May 2021 in JAMA Oncology

Authors: Fergus R. Macbeth | Raymond P. Abratt

Randomized Clinical Trials in the Era of Precision Oncology—The Role of End Points, Industry Funding, and Medical Writing Integrity

JOURNAL ARTICLE published 1 October 2021 in JAMA Oncology

Authors: Alessandro Rizzo | Veronica Mollica | Francesco Massari

A Poorly Differentiated Lung Malignancy in a Young Adult

JOURNAL ARTICLE published 1 December 2018 in JAMA Oncology

Authors: Radowan Elnair | Jacqulyn Choate | Fady Jamous

Treatment Options for Relapsed and Refractory Multiple Myeloma

JOURNAL ARTICLE published 1 October 2021 in JAMA Oncology

Authors: Samer Al Hadidi | Sarvari Yellapragada

Risk of COVID-19 in Patients With Cancer—Reply

JOURNAL ARTICLE published 1 September 2020 in JAMA Oncology

Authors: Melvin L. K. Chua | Jing Yu | Conghua Xie

Highlights

JOURNAL ARTICLE published 1 September 2017 in JAMA Oncology

Error in Author’s Name

JOURNAL ARTICLE published 1 May 2019 in JAMA Oncology

Demonstrating Noninferiority of Accelerated Radiotherapy With Panitumumab vs Standard Radiotherapy With Cisplatin in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma—Reply

JOURNAL ARTICLE published 1 October 2017 in JAMA Oncology

Authors: Bingshu E. Chen | Lillian L. Siu | Wendy R. Parulekar